Northern Trust’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-10,469
| Closed | -$7.64K | – | 4543 |
|
|
2026
Q1 | $7.64K | Hold |
10,469
| – | – | ﹤0.01% | 4382 |
|
|
2025
Q4 | $58.4K | Buy |
10,469
+6,900
| +193% | +$76.7K | ﹤0.01% | 4251 |
|
|
2025
Q3 | $26.3K | Hold |
3,569
| – | – | ﹤0.01% | 4354 |
|
|
2025
Q2 | $27.2K | Hold |
3,569
| – | – | ﹤0.01% | 4314 |
|
|
2025
Q1 | $68.1K | Buy |
3,569
+737
| +26% | +$23.2K | ﹤0.01% | 4185 |
|
|
2024
Q4 | $103K | Sell |
2,832
-55
| -2% | -$1.53K | ﹤0.01% | 4147 |
|
|
2024
Q3 | $83.2K | Hold |
2,887
| – | – | ﹤0.01% | 4102 |
|
|
2024
Q2 | $73.9K | Buy |
2,887
+365
| +14% | +$16.6K | ﹤0.01% | 4120 |
|
|
2024
Q1 | $191K | Buy |
2,522
+511
| +25% | +$40.5K | ﹤0.01% | 3912 |
|
|
2023
Q4 | $207K | Buy |
2,011
+443
| +28% | +$39.8K | ﹤0.01% | 3892 |
|
|
2023
Q3 | $153K | Buy |
1,568
+212
| +16% | +$19.8K | ﹤0.01% | 3905 |
|
|
2023
Q2 | $159K | Hold |
1,356
| – | – | ﹤0.01% | 3909 |
|
|
2023
Q1 | $114K | Sell |
1,356
-207
| -13% | -$18.1K | ﹤0.01% | 4051 |
|
|
2022
Q4 | $133K | Buy |
1,563
+1,034
| +195% | +$78.9K | ﹤0.01% | 4009 |
|
|
2022
Q3 | $17K | Hold |
529
| – | – | ﹤0.01% | 4574 |
|
|
2022
Q2 | $12K | Hold |
529
| – | – | ﹤0.01% | 4680 |
|
|
2022
Q1 | $26K | Hold |
529
| – | – | ﹤0.01% | 4642 |
|
|
2021
Q4 | $31K | Hold |
529
| – | – | ﹤0.01% | 4666 |
|
|
2021
Q3 | $43K | Hold |
529
| – | – | ﹤0.01% | 4554 |
|
|
2021
Q2 | $51K | Buy |
+529
| New | +$53.3K | ﹤0.01% | 4494 |
|
Other funds holding RVPH
Northern Trust's RVPH Position: Q2 2026 in Review
Northern Trust sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 10,469 shares — an estimated $7.64K sold.
Northern Trust first reported a position in RVPH in Q2 2021 and held it in 20 quarters. The position peaked at $207K in Q4 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.
- Northern Trust reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
- Northern Trust sold 10,469 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $7.64K.
- Northern Trust first reported a position in REVIVA PHARMA HLDGS INC in Q2 2021 and held it in 20 quarters.
- Northern Trust's REVIVA PHARMA HLDGS INC position peaked at $207K in Q4 2023.
- 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.